Spectrum Pharma receives FDA acceptance for Zevalin review
Zevalin is a CD20-directed radiotherapeutic antibody. Zevalin injection for intravenous use is indicated for the treatment of patients with previously untreated follicular non-Hodgkin’s Lymphoma (NHL), who achieve a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.